| Literature DB >> 34325554 |
Timon F G Vercoulen1, Remco J P Doodkorte1, Alex Roth1, Rob de Bie2, Paul C Willems1.
Abstract
STUDYEntities:
Keywords: adult spinal deformity; long-segment spinal fusion; proximal junctional failure; proximal junctional kyphosis; semi-rigid junctional fixation; spine surgery; systematic review; topping-off; transition zone
Year: 2021 PMID: 34325554 PMCID: PMC9210240 DOI: 10.1177/21925682211034500
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Figure 1.Surgical prophylactic techniques for PJK and PJF as reported in Table 1, (A) tether-connectors (TO) 28, 33; (B) tether only (TO) 29, 30, 32; (C) tether-crosslink (TC) 29, 30; (D) tether-pedicle loop (TO) 31; (E) tether in a figure 8 way (TO) 34; (F) prophylactic 2-level vertebroplasty (2-PVP) 32, 35-40; (G) transverse process hooks (TPH) 32, 41, 42; (H) flexible rods (FR) 43; (I) multilevel stabilization screw (MLSS) 44; (J) sublaminar tapes (ST) 45.
Figure 2.PRISMA 2009 flow diagram of the included studies. AIS = adult idiopathic scoliosis.
Study Characteristics.
| Author and study design | Groups and surgical technique description | Follow-up (mo) | Participants | Additional surgery | |
|---|---|---|---|---|---|
|
| |||||
| Alluri et al 2020
| PS | 23.4 ± 14.1 | N = 34 | Age 62 ± 9; M/F 13:21 | Ost. n = 30, ACP n = 3 |
| TC: semitendinosus allograft interwoven between spinous processes UIV+1 and a crosslink between the rods at UIV−2. | 18.2 ± 9.4 | N = 49 | Age 64 ± 10; M/F 13:36 | Ost. n = 44, ACP n = 9 | |
| Buell et al 2018
| PS | 28 (12-57)† | N = 64 | Age 66.1 ± 8.5; M/F 22:42 | Ost. n = 18 |
| TO: Hand-tightened 5-mm polyethylene tape through the spinous processes of UIV+1 and UIV−1 | 28 (12-57)† | N = 64 | Age 66.3 ± 10.9; M/F 31:43 | Ost. n = 17 | |
| TC: 5-mm polyethylene tape through the spinous processes of UIV+1 and tensioned by distal displacement of a crosslink between UIV−1 and UIV−2 | 28 (12-57)† | N = 56 | Age 66.6 ± 8.6; M/F 17:39 | Ost. n = 8 | |
| Buell et al 2019
| PS + TO + TC: Pedicle screws at UIV or polyethylene tape tied through the spinous processes of UIV+1 and either tied to UIV−1 or to a standard crosslink between UIV−1 and UIV−2. | 20 (3-56) | N = 120 | Age 67.3 ± 8.2; M/F 43:77 | Ost. n = 22 |
| Iyer et al 2020
| PS | 17.6 ± 6.1 | N = 77 | *Age 51.3 ± 21.4 | *Ost. n = 51, |
| TO: 5-mm polyethylene tape through spinous processes of UIV+1 and looped below pedicle screws of UIV. This process was repeated at UIV, tied to UIV−1. | 17.4 ± 6.0 | N = 31 | *Age 64.1 ± 10.4 | *Ost. n = 28, | |
| Line et al 2020
| PS | 31.2 (8-83)† | N = 390 | Age 62.2 (19-86); M/F 121:296 | Unclear |
| TO: Polyethylene tape tied through the spinous processes of UIV+1 (and/or UIV+2) and UIV−1, reference to Buell et al 2019
| 31.2 (8-83)† | N = 62 | Age 65.9 (41-84); M/F 15:47 | ||
| Safaee et al 2018
| PS | 12 (6-26)† | N = 100 | *Age 62; M/F 29:71 | *UIV hook n = 18 |
| TO: Two soft translaminar cables are passed through the center of the spinous processes at UIV, UIV+1 and UIV−1, then the cable ends are locked to connecters bilaterally between UIV−2 and UIV−3 | 12 (6-26)† | N = 100 | *Age 66 (25-84); M/F 33:67 | Ost. n = 4 | |
| Rodriguez-Fontan et al 2019
| PS | Minimum 24 | N = 60 | Age 62.1 ± 11.2; M/F 20:40 | Ost. n = 37 |
| TO: 5-mm braded polyethylene tape passed through the spinous process of UIV+1 and looped in a figure 8 way around the infra-adjacent spinous process and eventually tied through a cross-link or to the rods bilaterally. | Minimum 24 | N = 20 | Age 63.2 ± 10.9; M/F 9:11 | Ost. n = 10 | |
|
| |||||
| Ghobrial et al 2017
| PS | 27.9 ± 13.4 | N = 47 | *Age 58.3 ± 10.6; *M/F 14:33 | Dec. n = 34, Ost. n = 32 |
| 2-PVP: Prophylactic vertebroplasty at UIV and UIV+1 | 24.2 ± 9.77 | N = 38 | *Age 71.0 ± 6.8; *M/F 23:15 | Dec. n = 5, Ost. n = 28 | |
| Han et al 2019
| PS | 22.6 ± 11.7 | N = 56 | Age 70.0 ± 5.1; M/F 55:51 | Ost. n = 36, |
| 2-PVP: Prophylactic vertebroplasty at UIV and UIV+1 | 19.8 ± 13.3 | N = 28 | Age 70.8 ± 7.1 M/F 0:28 | Ost. n = 12 | |
| Hart et al 2008
| PS | 15.5 (13-49) | N = 13 | Age 67.3 (60-77); M/F 0:15 | Unclear |
| 2/3-PVP: Prophylactic vertebroplasty at UIV and UIV+1 and/or UIV−1 | 17.3 (12-44) | N = 15 | Age 73.9 (60-87); M/F 0:13 | ||
| Line et al 2020
| PS | 31.2 (8-83)† | N = 390 | Age 62.2 (19-86); M/F 121:296 | Unclear |
| 2-PVP: Prophylactic vertebroplasty at UIV and UIV+1 | 31.2 (8-83)† | N = 58 | Age 65.0 (41-84); M/F 11:47 | ||
| Martin et al 2013
| 2-PVP: Prophylactic vertebroplasty at UIV and UIV+1 | 32.3 (24-48) | N = 41 | Age 64.4 (41-80); M/F 4:34 | Ost. n = 27 |
| Raman et al 2017
| 2-PVP: Prophylactic vertebroplasty at UIV and UIV+1 | 67.9 ± 30.9 | N = 39 | Age 65.6 ± 8.8; M/F 5:34 | Unclear |
| Theologis and Burch 2015
| PS | 24.9 ± 15.4 | N = 23 | *Age 59.8 ± 13.0; M/F 9:14 | Ost. n = 9 |
| 1-PVP at UIV or UIV+1/2-PVP at UIV and UIV−1/3-PVP at UIV, UIV+1 and UIV−1 | 20.4 ± 15.6 | N = 9 | *Age 72.4 ± 7.8; M/F 4:5 | Ost. n = 3 | |
| 2-PVP: Prophylactic vertebroplasty at UIV and UIV+1 | 14.8 ± 8.3 | N = 19 | *Age 68.2 ± 6.3; M/F 9:10 | Ost. n = 6 | |
|
| |||||
| Hassanzadeh et al 2013
| PS | 68.4 (44-88) | N = 27 | Age 51 (20-78); M/F 5:22 | Unclear |
| TPH: Transverse process hooks placed directly lateral to the lateral edge of the pedicle | 33,6 (24-69) | N = 20 | Age 46 (22-78); M/F 3:17 | ||
| Line et al 2020
| PS | 31.2 (8-83)† | N = 390 | *Age 62.2 (19-86); M/F 121:296 | Unclear |
| TPH: Transverse process hooks at UIV | 31.2 (8-83)† | N = 115 | *Age 58.8 (19-84); M/F 37:78 | ||
| Matsumura et al 2018
| PS | 42.9 (24-91)† | N = 22 | Age 65.5(42-83); M/F 2:37† | Ost. n = 10 |
| TPH: Transverse process hooks at UIV | 42.9 (24-91)† | N = 17 | Age 69.3 (46-81); M/F 2:37† | ||
| Flexible rod (FR) | |||||
| Lee et al 2019
| Unclear / No-FR | 36.7 ± 9.8 | N = 47 | Age 71.6 ± 5.1; M/F 2:75† | *L2 Ost. n = 39, |
| FR: Flexible (Ti6Al-4 ELI alloy) rod allowing 15° flexion and 10° extension at the proximal junction. | 16.8 ± 4.7 | N = 30 | Age 71.8 ± 5.2; M/F 2:75† | *L2 Ost. n = 10 | |
|
| |||||
| Sandquist et al 2015
| MLSS: PS at UIV is passed in a superior and oblique manner, ending in the vertebral body of UIV+1 | 30.7 (14-45) | N = 15 | Age 66.3 (44-84); M/F 4:11 | Unclear |
|
| |||||
| Viswanathan et al 2018
| ST: Sublaminar tapes at UIV+1 introduced from the inferior to the superior end bilaterally. | 12 (IQR 6-15) | N = 40 | Age 64 (57-70); M/F 16:24 | Laminectomies, |
Values are presented as “mean value ± Standard Deviation” or “median (range).”
* Indicates that the mentioned study has reported these values as significantly different between groups.
†Indicates that the mentioned study only reported these values for the entire cohort, not per intervention group.
2-PVP: 2-level prophylactic vertebroplasty, ACP: anterior column procedure, Ant.: anterior, A-, P-, O-LIF: anterior-, posterior-, oblique lumbar interbody fusion, BMI: body mass index (kg/m2), FR: flexible rod, IBF: interbody fusion, Dec: Decompression, IQR: Interquartile range, Levels: amount of levels fused, M/F: male/female ratio, MLSS: multilevel stabilization screws, n: number of patients, PS: pedicle screw at the UIV (control group), Ost.: osteotomy, SH: sublaminar hooks, ST: sublaminar tapes, TC: tether attached to crosslink at the UIV, TO: tether only at the UIV, TPH: transverse process hooks, UIV: upper instrumented vertebrae.
Risk of Bias Measured Using the ROBINS-I Tool.
| Bias due to confounding | Bias in selection of participants | Bias in classifications of interventions | Bias due to deviations from intended interventions | Bias due to missing outcome data | Bias in measurement of the outcome | Bias in selection of the reported results | Overall risk of bias | |
|---|---|---|---|---|---|---|---|---|
| Alluri et al 2020
|
|
|
|
|
|
|
|
|
| Buell et al 2018
|
|
|
|
|
|
|
|
|
| Buell et al 2019
|
|
|
|
|
|
|
|
|
| Ghobrial et al 2017
|
|
|
|
|
|
|
|
|
| Han et al 2019
|
|
|
|
|
|
|
|
|
| Hart et al 2008
|
|
|
|
|
|
|
|
|
| Hassanzadeh et al 2013
|
|
|
|
|
|
|
|
|
| Iyer et al
|
|
|
|
|
|
|
|
|
| Lee et al 2019
|
|
|
|
|
|
|
|
|
| Line et al 2020
|
|
|
|
|
|
|
|
|
| Matsumura et al 2018
|
|
|
|
|
|
|
|
|
| Martin et al 2013
|
|
|
|
|
|
|
|
|
| Raman et al 2017
|
|
|
|
|
|
|
|
|
| Rodriguez-Fontan et al 2019
|
|
|
|
|
|
|
|
|
| Safaee et al 2018
|
|
|
|
|
|
|
|
|
| Sandquist et al 2015
|
|
|
|
| ? |
|
|
|
| Theologis and Burch 2015
|
|
|
|
|
|
|
|
|
| Viswanathan et al 2018
|
|
|
|
|
|
|
|
|
| Overall risk of bias criteria: | ||||||||
Primary and Secondary Outcomes.
| Title | Definition of PJK used in study | Definition of PJF used in study | Group | PJK | RR | PJF incidence | Clinical outcome | Complications |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Alluri et al 2020
| PJK necessitating revision surgery | PS | 32% | 18% |
| ODI*, | All 62% | |
| TC | 33% | 0% |
| ODI*, | All 49% | |||
| Buell et al 2018
| Mechanical failure at UIV or just above and/or proximal junctional posterior discoligamentous failure | PS | 45%* | 5% | 5% |
|
| |
| TO | 34% | 9% | 9% |
| “None related to tether” | |||
| TC | 18%* | 4% | 4% |
| “None related to tether” | |||
| Buell et al 2019
| None, although revision surgery for PJK is mentioned | PS | 55% | 6% |
|
|
| |
| TO + TC | 32% | 5% |
|
| “None related to tether” | |||
| Iyer et al 2020
| PJF not reported | PS | 29% | 5% |
|
|
| |
| TO | 27% | 0% |
|
|
| |||
| Line et al 2020
|
| PJA ≥ 28.0° and change PJA ≥ 21.6° OR | PS |
|
| 20% |
|
|
| TO |
|
| 16% |
|
| |||
| Safaee et al 2018
| PJK requiring surgical revision | PS |
| 18%* |
|
|
| |
| TO | 16% | 4%* |
|
|
| |||
| Rodriguez-Fontan et al
| Symptomatic PJK with or without instrumentation failure and or vertebral fracture at UIV+2 | PS | #38% |
| #38% |
|
| |
| TO | #15% |
| #15% |
|
| |||
|
| ||||||||
| Ghobrial et al 2017
| Revision surgery as a consequence of PJK (Proximal extension of fusion), or refractory pain | PS | 36%* | 13%* | 16% |
| Major: 16†, Minor: 6† | |
| 2-PVP | 24%* | 0%* | 0% |
| Major: 16†, Minor: 6† | |||
| Han et al 2019
| Bony failure, ligamentous failure, instrument failure (implant breakage and pullout of UIV fixation). | PS | 46% | 14% | 32% |
| Major 7, Minor 2 | |
| 2-PVP | 46% | 4% | 39% |
| Major 1, Minor 2 | |||
| Hart et al 2008
|
| Proximal junctional acute collapse requiring extension of instrumented fusion | PS |
|
| 15% |
|
|
| 2-PVP / 3-PVP |
|
| 0 |
| “None related to 2-PVP” | |||
| Line et al 2020
|
| (see Line et al 2020 above) | PS |
|
| 20% |
|
|
| 2-PVP |
|
| 12% |
|
| |||
| Martin et al 2013
| acute proximal junctional fracture/fixation failure or substantial PJK that required revision or extension of the fusion proximally | 2-PVP | 8% | 5% | 5% |
| Major 6, Minor 13 | |
| Raman et al 2017
| Proximal junctional fracture, fixation failure or kyphosis requiring extension of fusion within 6 months of surgery | 2-PVP | 28% | 5% | 5% |
| Major 21, Minor 19 | |
| Theologis and Burch 2015
|
| Proximal junctional fracture | PS |
|
| 21% | ODI* |
|
| PVP |
|
| 22% |
|
| |||
| 2-PVP |
|
| 5% |
|
| |||
|
| ||||||||
| Hassanzadeh et al 2013
| PJF not reported | PS | 30%* | 7%* |
| ODI*, | Major 7, Minor 15 | |
| TPH | 0%* | 0%* |
| ODI*, | Major 3, Minor 13 | |||
| Line et al 2020
|
| (see Line et al 2020 above) | PS |
|
| 20% |
|
|
| TPH |
|
| 7% |
|
| |||
| Matsumura et al 2018
|
| Fracture at UIV (Fx) or PJA > 20° (PJA) | PS |
|
| 27% (27%PJFx, |
|
|
| TPH |
|
| 18% (12% PJFx, 6% PJA > 20°) |
|
| |||
|
| ||||||||
| Lee et al 2019
| Classified as progressive PJK or PJFx | PS | 53%* |
| 15% |
|
| |
| 38% |
|
| ||||||
| FR | 10%* |
| 0 |
|
| |||
| 0% |
|
| ||||||
|
| ||||||||
| Sandquist et al 2015
|
| None, although revision surgery for fractures or instrumentation failure at the proximal junction is reported | MLSS | 0% |
| 0% |
|
|
|
| ||||||||
| Viswanathan et al 2018
|
| Unclear | SLB | 8% |
| 0% |
| Major 9, Minor 27 |
Data is presented as relative value (%).
*Indicates that the mentioned study has reported these values as significantly different between groups.
‡Indicates that the mentioned study reported a significant improvement from pre-operative to final follow-up.
#Indicates that the mentioned study reported PJK and PJF combined, and did not report separate values.
2-PVP: 2-level prophylactic vertebroplasty, FR: flexible rod, MLSS: multilevel stabilization screws, PJA: proximal junctional angle, PJFx: proximal junctional fracture, PS: pedicle screw at the UIV (control group), RR: revision rate for PJK, ST: sublaminar tapes, TC: tether attached to crosslink at the UIV, TO: tether only at the UIV, TPH: transverse process hooks, UIV: upper instrumented vertebrae.
Clinical Outcome Data Presented per Study.
| Author | Clinical outcome measure | Preoperative value | Final follow-up value | Delta | ||
|---|---|---|---|---|---|---|
| Tether (tether only (TO) + tether and crosslink (TC)) | ||||||
| Alluri et al 2020
| ODI | PS | 61 | 55* | 6* | |
| TC | 58 | 42* | 16* | |||
| 2 level prophylactic vertebroplasty (2-PVP) | ||||||
| Martin et al 2013
| ODI | 82.88 | 25.04‡ | 57.84 | ||
| SF-36 | Physical health | 45.83 | 41.46‡ | 4.37 | ||
| Mental health | 70.2 | 51.21‡ | 18.99 | |||
| SRS-24 | Function/activity | 54.22 | 64.74‡ | 10.52 | ||
| Pain | 44.31 | 70.61‡ | 26.3 | |||
| Mental health | 54.90 | 58.71‡ | 3.81 | |||
| Satisfaction | 53.05 | 74.75‡ | 21.70 | |||
| Theologis and Burch 2015
| EQ | VAS | PS | 71 ± 19 (n = 18) | 61 ± 22 (n = 22) | 10 |
| 2-PVP | 63 ± 25 (n = 19) | 74 ± 23 (n = 18) | 11* | |||
| 5-D Utility | PS | 0.44 ± 0.21 (n = 18) | 0.50 ± 0.22 (n = 22) | 0.06 | ||
| 2-PVP | 0.51 ± 0.18 (n = 19) | 0.65 ± 0.22 (n = 18) | 0.14* | |||
| ODI | PS | 52 ± 20 (n = 18) | 47 ± 18 (n = 22)‡ | 5 | ||
| 2-level vertebroplasty | 47 ± 14 (n = 13) | 32 ± 17 (n = 17)‡ | 15* | |||
| VAS | Back pain | PS | 5.9 ± 3.0 (n = 14) | 5.2 ± 1.9 (n = 12) | 0.7 | |
| 2-PVP | 6.8 ± 2.6 (n = 5) | 3.4 ± 3.4 (n = 10) | 3.4* | |||
| Leg pain | PS | 6.0 ± 3.4 (n = 14) | 2.4 ± 2.7 (n = 12) | 3.6* | ||
| 2-PVP | 4.0 ± 3.4 (n = 7) | 1.2 ± 2.0 (n = 10) | 2.8* | |||
| Transverse process hooks (TPH) | ||||||
| Hassanzadeh et al 2013
| ODI | PS | 72 (48-90) | 32 (0-54‡ | 40 | |
| TPH | 76 (52-90) | 18 (8-38)‡ | 58 | |||
| SRS-22 | Function | PS | 2.4 (1.7-3) | 3.1 (2.5-3.7)‡ | 0.7* | |
| TPH | 2.4 (1-3.3) | 3.6 (3-4.1)‡ | 1.2* | |||
| Pain | PS | 1.7 (0.3-3.1) | 3.2 (2.6-4.3)‡ | 1.5* | ||
| TPH | 1.8 (0.9-2.4) | 4.3 (3.4-4.8)‡ | 2.5* | |||
| Self-image | PS | 2.1 (0.9-3) | 2.4 (1.2-3.6)‡ | 0.3* | ||
| TPH | 1.8 (0.5-3.4) | 4.2 (2.6-5.3)‡ | 2.4* | |||
| Mental Health | PS | 1.8 (1.1-2.5) | 3 (2.3-3.3)‡ | 1.2* | ||
| TPH | 1.7 (1.2-2.6) | 3.8 (3.2-4.1)‡ | 2.1* | |||
| Satisfaction | PS | 1.2 (0.1-4.5) | 3.4 (2.3-4.6)‡ | 2.2* | ||
| TPH | 1.6 (0-4.1) | 4.3 (3.5-5.5)‡ | 3.2* | |||
| Sublaminar tapes (ST) | ||||||
| Viswanathan | ODI | 56.0 (45.0-64.0) | 46.0 (22.2-54.0) | 10.0* | ||
| VAS | Pain | 12.5 (0.0-22.5) | 45.0 (22.5-67.5) | 32.5* | ||
| Back pain | 8.0 (6.0-10.0) | 2.0 (0.0-6.0) | 6.0* | |||
| Leg pain | 8.0 (6.0-10.0) | 0.5 (0.0-5.0) | 7.5 | |||
| SF-36 | Physical | 20.0 (5.0-30.0) | 32.5 (17.5-53.8) | 12.5* | ||
| Social functioning | 37.5 (12.5-50.0) | 56.3 (37.5-96.9) | 18.8* | |||
Data is presented as “mean value ± Standard Deviation” or “median (range).”
* Indicates that the mentioned study has reported these values as significantly different between groups.
‡Indicates that the mentioned study reported a significant improvement from pre-operative to final follow-up.
2-PVP: 2-level prophylactic vertebroplasty, PS: pedicle screw at the UIV (control group), ST: sublaminar tapes, TPH: transverse process hooks.